Uncategorized

The changes support accuracy across diverse patient populations, skin tones and clinical care settings.

The rollout marks the second wave of deployments in 2026 after the VA largely paused the project for years to fix technical issues and errors.

New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.

The state said it intends to divvy out new contracts, which represent tens of billions of dollars in revenue for each awardee, to six insurers. Winners are mostly incumbents, except for Humana.

With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.

While Merck and Gilead Sciences reported back-to-back late-stage victories for their weekly HIV pill, the partners also discontinued a Phase 3 program for their cancer combo after disappointing lung cancer survival data.

The public biotech universe has shrunk by more than 20% since 2021, yet financial stress remains entrenched across the sector.

Una nueva tecnología permite convertir en materiales biodegradables ciertos residuos vegetales como la lignina, que es uno de los compuestos orgánicos más abundantes del mundo. De este modo, se consigue un aprovechamiento sostenible de residuos vegetales y se ofrecen alternativa …

Unos astrónomos han encontrado la evidencia más sólida hasta ahora de actividad magnética en mundos de fuera de nuestro sistema solar.   El campo magnético de la Tierra actúa como un escudo: ayuda a impedir que la radiación cósmica arras …

Nuvalent Bio is GSK’s third big-ticket purchase this year, after the pharma dropped $2.2 billion in January for RAPT Therapeutics and $950 million in February for 35Pharma.